Ranbaxy : Bad new for stock, Sell above 534.90 for tgt 507.90 and below.

Ranbaxy may be under pressure as the US government has sued Ranbaxy for concealing and forging crucial data to get a favourable judgment in an ongoing investigation.

Ranbaxy : Bad new for stock, Sell above 534.90 for tgt 507.90 and below.